Roche Genentech

Pharma - Large Cap Biotech of the Year

The Award

This award recognises the pharma or large cap company that has demonstrated a superior excellence in strategy, process, focus and execution to create significant value for patients, shareholders and investors, employees and the broader community.

Judges paid particular attention to:

  • Targeting unmet medical need/innovative approaches to pipeline development.
  • Pipeline progress through drug discovery/pre-clinical/clinical stages.
  • Progress of pipeline through to market approval.
  • Key stages of strategic development/partnerships.
  • Shareholder ROI/share price.

Company Description  

Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for over 40 years.

Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. We are among the world's leading biotech companies, with multiple products on the market and a promising development pipeline.